Skip to main content

Master of Public Health

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.

AUTHORS

Nayagam S , Conteh L , Sicuri E , Shimakawa Y , Suso P , Tamba S , Njie R , Njai H , Lemoine M , Hallett TB , Thursz M , . The Lancet. Global health. 2016 8 1; 4(8). e568-78

ABSTRACT

Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, absence of widespread screening and poor access to treatment leads to most people remaining undiagnosed until later stages of disease when prognosis is poor and treatment options are limited. We examined the cost-effectiveness of community-based screening and early treatment with antiviral therapy for HBV in The Gambia.

Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, absence of widespread screening and poor access to treatment leads to most people remaining undiagnosed until later stages of disease when prognosis is poor and treatment options are limited. We examined the cost-effectiveness of community-based screening and early treatment with antiviral therapy for HBV in The Gambia.

Tags: